Effect of antifungal therapy on hematological recovery after intensive antileukemic chemotherapy

Haematol Blood Transfus. 1990:33:558-9. doi: 10.1007/978-3-642-74643-7_100.
No abstract available

MeSH terms

  • Agranulocytosis / chemically induced
  • Agranulocytosis / physiopathology*
  • Antifungal Agents / pharmacology*
  • Antifungal Agents / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Cytarabine / administration & dosage
  • Daunorubicin / administration & dosage
  • Depression, Chemical
  • Hematopoiesis / drug effects*
  • Humans
  • Leukemia, Myeloid, Acute / complications
  • Leukemia, Myeloid, Acute / drug therapy
  • Leukemia, Myelomonocytic, Acute / complications
  • Leukemia, Myelomonocytic, Acute / drug therapy
  • Life Tables
  • Mitoxantrone / administration & dosage
  • Mycoses / drug therapy*
  • Mycoses / etiology
  • Thioguanine / administration & dosage
  • Thrombocytopenia / chemically induced
  • Thrombocytopenia / physiopathology*

Substances

  • Antifungal Agents
  • Cytarabine
  • Mitoxantrone
  • Thioguanine
  • Daunorubicin

Supplementary concepts

  • DAT protocol 1
  • NOAC protocol